Functional and mechanistic investigations further revealed that KIFC2 promoted growth and conferred resistance to Tam and CDK4/6 inhibitors in HR+/HER2– BC by recruiting ubiquitin-specific peptidase 9 X-linked (USP9X) to stabilize CDK4. Here, USP9X is linked to breast cancer.